Blood chemistry is regulated by negative feedback in order to keep the body in homeostasis (optimal equilibrium). The levels of glucose in the blood are monitored by the cells in the pancreas.
If the blood glucose level falls to dangerous levels (caused by very heavy exercise or lack of food for extended periods), some pancreas cells release glucagon, a hormone that acts on liver cells to increase blood glucose levels.
Stored glycogen is converted into glucose by a process called glycogenolysis. The glucose is then released into the bloodstream, increasing blood sugar levels.
Blood sugar levels are also increased by "stress" hormones such as adrenalin, steroids, infections, trauma, and the ingestion of food. When levels of blood sugar rise, whether as a result of glycogen conversion, or from the digestion of a meal, a different hormone is released from beta cells found in the Islets of Langerhans in the pancreas.
This hormone, insulin, causes the liver to convert more glucose into glycogen. This process is called glycogenesis and it forces about two-thirds of body cells (primarily muscle and fat tissue cells) to take up glucose from the blood, thereby decreasing blood sugar levels. A breakdown in body homeostasis can lead to dangerously high or low blood sugar levels.
This can become a chronic condition leading to the onset of diabetes. According to the World Health Organization, in 1985, an estimated 30 million people worldwide had diabetes. By 1995, this number shot up to 135 million. The latest WHO estimate for the number of people with diabetes worldwide is 177 million. This will increase to at least 300 million by 2025.
The number of deaths attributed to diabetes is likely to be around 4 million. These projections take into account the fact that there will be more people in the world due to population growth and that there will be more elderly people due to population aging.
They also account for urbanization - the fact that people are moving from rural areas to cities, particularly in developing countries. This migration affects the number of people who are likely to have diabetes, because people living in cities of developing countries tend to be less physically active and have higher levels of obesity than people in rural areas.
In fact, current trends in obesity suggest that these projections are conservative and that the increase in the prevalence of diabetes may be even greater. In developing countries, people in the middle and most productive years of their lives are particularly affected by diabetes.
In these countries, three-quarters of all people with diabetes are under 65 years old and 25% of all adults with diabetes are younger than 44. In developed countries, more than half of all people with diabetes are older than 65, and only 8% of adults with diabetes are younger than 44. Because of its chronic nature, the severity of its complications, and the means required to control it, diabetes is a costly disease, not only for the affected individuals and the families involved, but also for the health authorities.
Studies in India estimate that, for a low-income Indian family, as much as 25% of family income may be devoted to diabetes care. For families in the USA, the corresponding figure is 10%. The total healthcare cost of a person with diabetes in the USA is between two and three times those for people without the condition.
A recent analysis of healthcare expenditure in the Western Pacific region has shown that 16% of hospital expenditure was spent on people afflicted with diabetes. In the Republic of the Marshall Islands, this figure was 25%. The cost of diabetes affects everyone, everywhere, but they are not only a financial problem. Intangible costs (pain, anxiety, inconvenience, and generally lower quality of life) also have great impact on the lives of patients and their families and are the most difficult to quantify.
Direct costs to individuals and their families include medical care, drugs, insulin, and other supplies. Patients may also have to bear other personal costs, such as increased payments for health and life insurance. Recent treatment cost estimates for Argentina, Brazil, and Mexico were US $3.9 billion, US $0.8 billion and US $2.0 billion, respectively.
Each of these is an annual figure and is rising as prevalence of diabetes increases. For most countries, the largest portion of diabetes expenditure is cost of hospital admissions for the treatment of long-term complications, such as heart disease, stroke, kidney failure, and foot problems.
Western medicine relies on aggressive prescription drugs and surgery to deal with many problems related to irregular blood chemistry in the body. Unfortunately, these methods often result in unwanted and even dangerous side effects. And natural pills provide only fleeting, inconsistent results.
Ayurveda, the science of life, prevention and longevity, is the oldest and most holistic and comprehensive medical system available. Its fundamentals can be found in Hindu scriptures called the Vedas - the ancient Indian books of wisdom written over 5,000 years ago. Ayurveda applies the inherent principles of nature to help maintain optimum health in a person by keeping the individual's body, mind, and spirit in perfect equilibrium with nature.
India Herbs has a seasoned group of Ayurvedic doctors specialized in Vajikarana, one of the eight major specialties of Ayurveda. Vajikarana prescribes the therapeutic use of various herbal and tonic preparations to address the root cause of irregular blood chemistry, while strengthening your body and overall well-being.
India Herbs' Vajikarana scientists combine a proprietary herbal formula based on centuries' old wisdom with advice on diet, exercise, mental training, and relaxation to help men and women overcome their health concerns through safe and natural means.
Results: The precise combination of ingredients in AyurGold along with a mind-body focus precisely addresses your blood chemistry concerns!